AUTOTAC

Live / Applied — Second extension granted (statement of use) (as of 24 Apr 2025)

What this means for you

Not registered yet, but its 10 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97930680
Mark type
Stylized text
Filed
10 May 2023
Published for opposition
05 Mar 2024
Attorney of record
Muzamil Huq

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, neurodegenerative disease, neuropsychiatric disorders, cardiometabolic disease, diseases of the eye, dermatological diseases, pain, monogenic disorders, and hereditary diseases

Owner

Prosecution history

  • 18 Feb 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 31 Dec 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 27 Oct 2025 — SOU TEAS EXTENSION RECEIVED
  • 24 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 24 Apr 2025 — SOU EXTENSION 2 GRANTED
  • 24 Apr 2025 — SOU EXTENSION 2 FILED
  • 23 Apr 2025 — SOU TEAS EXTENSION RECEIVED
  • 02 Dec 2024 — REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
  • 02 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 02 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
  • 29 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 29 Aug 2024 — SOU EXTENSION 1 GRANTED
  • 29 Aug 2024 — SOU EXTENSION 1 FILED
  • 29 Aug 2024 — SOU TEAS EXTENSION RECEIVED
  • 15 May 2024 — ASSIGNED TO EXAMINER

View this trademark record on Marksy